The Research and Development Center of Precision Medicine, 3D Medicines Inc., Shanghai, P.R. China
Biography
The Research and Development Center of Precision Medicine, 3D Medicines Inc., Shanghai, P.R. China, EGFR; Erlotinib; Osimertinib; Lung adenocarcinoma; Circulating tumor DNA assay, EGFR Primary T790M and L858R Double Mutation Confers Clinical Benefit to Erlotinib and Resistance to Osimertinib in One Lung Adenocarcinoma Patient: A Case Report